News

Search:

Amidst European PIP Scandal, FDA Approves New Breast Implant Product

0 Likes

The US Food and Drug Administration (FDA) approved Sientra, Inc.’s breast implant product on 9 March, making Sientra the third approved marketer for breast implant products in the US.The approval Read More...

Tags:

Breast Augmentation

Breast Implant

CDRH

Cosmetic

FDA

Implant

PIP

SIentra

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Related News

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

Amidst European PIP Scandal, FDA Approves New Breast Implant Product

Get RF Today